Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Completed × Pneumonia × Clear all

Phase

Phase NA 5 Phase 2 5 Phase 4 1 Phase 3 1

Status

Terminated 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 492 Neoplasms 253 Prostatic Neoplasms 226 Carcinoma, Non-Small-Cell Lung 223 Colorectal Neoplasms 177 Multiple Myeloma 155 Neoplasm Metastasis 124 Lung Neoplasms 119 Leukemia, Myeloid, Acute 104 Leukemia 97 Lymphoma 96 Lymphoma, Follicular 94 Stomach Neoplasms 88 Lymphoma, Non-Hodgkin 87 Precursor Cell Lymphoblastic Leukemia-Lymphoma 82 Ovarian Neoplasms 80 Head and Neck Neoplasms 79 Rectal Neoplasms 77 Colonic Neoplasms 76 Uterine Cervical Neoplasms 74 Carcinoma, Hepatocellular 74 Pancreatic Neoplasms 73 Pain 72 Leukemia, Lymphocytic, Chronic, B-Cell 72 Melanoma 68 Papillomavirus Infections 58 Lymphoma, Large B-Cell, Diffuse 56 Brain Neoplasms 56 Squamous Cell Carcinoma of Head and Neck 55 Keratosis, Actinic 55

Interventions

Methylprednisolone 1 Etanercept 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00421174 2021-11-01

BMTCTN0403

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed

37 enrolled 20 charts

Pneumonia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡